UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 6.583

Sortiert nach

1-Amino-1,2,3,4-tetrahydronaphthalene-2-carboxylic acid as a Tic mimetic: Application in the synthesis of potent human melanocortin-4 receptor selective agonists

Bioorganic & medicinal chemistry letters, 2005-07, Vol.15 (14), p.3430-3433

2005

Volltextzugriff (PDF)

100 Gbit/s WDM transmission at 2 µm: transmission studies in both low-loss hollow core photonic bandgap fiber and solid core fiber

Optics express, 2015-02, Vol.23 (4), p.4946-4951

2015

Volltextzugriff (PDF)

1010P - Frequency of mutations in 21 hereditary breast and ovarian cancer susceptibility genes among 882 high-risk individuals

Annals of oncology, 2019-10, Vol.30, p.v413-v413

2019

Volltextzugriff (PDF)

1010PFrequency of mutations in 21 hereditary breast and ovarian cancer susceptibility genes among 882 high-risk individuals

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

1036 A 24-WEEK, PARALLEL-GROUP, OPEN-LABEL, RANDOMIZED CLINICAL TRIAL COMPARING THE EARLY ANTIVIRAL EFFICACY OF TELBIVUDINE AND ENTECAVIR IN THE TREATMENT OF HBEAG-POSITIVE CHRONIC HEPATITIS B

Journal of hepatology, 2010, Vol.52, p.S401-S401

2010

Volltextzugriff (PDF)

1073 GENOME-SCALE CRISPR/CAS9 SCREENING REVEALS THE ROLE OF PSMD4 IN COLIBACTIN-MEDIATED CELL CYCLE ARREST

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-253-S-253

2024

Volltextzugriff (PDF)

108 Denosumab in men with non-metastatic castration-resistant prostate cancer (CRPC) and PSA doubling time (PSADT) ≤6 months

European urology supplements : official journal of the European Association of Urology, 2013-03, Vol.12 (1), p.e108-e109

2013

Volltextzugriff (PDF)

108P Optimization of automatic emphysema detection in lung cancer screening dataset

Journal of thoracic oncology, 2023-04, Vol.18 (4), p.S102

2023

Volltextzugriff (PDF)

A 112.5Gb/s ADC-DSP-Based PAM-4 Long-Reach Transceiver with >50dB Channel Loss in 5nm FinFET

2022 IEEE International Solid- State Circuits Conference (ISSCC), 2022, Vol.65, p.116-118

2022

Volltextzugriff (PDF)

118P Non-invasive plasma cell-free 5-hydroxymethylcytosine as promising biomarkers for early diagnosing gastrointestinal cancers

Annals of oncology, 2023-11, Vol.34, p.S1516

2023

Volltextzugriff (PDF)

1213P HRD complete: A novel NGS assay for detecting homologous recombination repair (HRR) gene alterations in prostate cancer

Annals of oncology, 2023-10, Vol.34, p.S713-S713

2023

Volltextzugriff (PDF)

1215 Ritlecitinib, an oral dual JAK3/TEC family kinase inhibitor, induces differential changes in immunological protein levels across Fitzpatrick skin types (FST) in patients with active nonsegmental vitiligo (NSV)

Journal of investigative dermatology, 2023-05, Vol.143 (5), p.S208-S208

2023

Volltextzugriff (PDF)

132TiP Dose escalation of chemoradiotherapy in locally advanced esophageal squamous cell carcinoma based on positron emission tomography response: A phase III, open-label, randomized, controlled trial (ESO-Shanghai 12)

Annals of oncology, 2022-11, Vol.33, p.S1483-S1483

2022

Volltextzugriff (PDF)

(134) Symptom burden clusters in underserved Chinese American cancer patients

The journal of pain, 2014-04, Vol.15 (4), p.S9-S9

2014

Volltextzugriff (PDF)

135P Simultaneous noninvasive imaging of LAG-3 and PD-L1 for noninvasive immunotyping in lung cancers

ESMO open, 2024-03, Vol.9, p.102723, Article 102723

2024

Volltextzugriff (PDF)

1378P A single-center, prospective, open-label, single-arm trial of sintilimab with paclitaxel and carboplatin as a neoadjuvant therapy for esophageal squamous carcinoma

Annals of oncology, 2021-09, Vol.32, p.S1042-S1043

2021

Volltextzugriff (PDF)

152P A phase I study of HBM4003, an anti-CTLA-4 heavy chain only monoclonal antibody, in combination with toripalimab in advanced melanoma

Immuno-oncology technology, 2022-12, Vol.16, p.100264, Article 100264

2022

Volltextzugriff (PDF)

155P Surufatinib plus toripalimab for second-line treatment of advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma, esophageal squamous cell carcinoma (ESCC) and neuroendocrine carcinoma (NEC): A multicenter, single-arm phase II study

Annals of oncology, 2021-12, Vol.32, p.S1448

2021

Volltextzugriff (PDF)

172P Trastuzumab deruxtecan (T-DXd) in Chinese patients (pts) with previously treated HER2-positive locally advanced/metastatic gastric cancer (GC) or gastroesophageal junction adenocarcinoma (GEJA): Primary efficacy and safety from the phase II single-arm DESTINY-Gastric06 (DG06) trial

Annals of oncology, 2023-11, Vol.34, p.S1542-S1543

2023

Volltextzugriff (PDF)

174P A real-world study of PD-1 inhibitors combined with TKIs for HCC with major vascular invasion as the conversion therapy: A prospective, non-randomized, open-label cohort study

Annals of oncology, 2020-11, Vol.31, p.S1307-S1307

2020

Volltextzugriff (PDF)

181P TQB2450 (PD-L1 blockade) in combination with anlotinib as a perioperative treatment for patients with hepatocellular carcinoma at high risk of recurrence: Primary results from a prospective, single-arm, phase Ib study

Annals of oncology, 2023-11, Vol.34, p.S1545

2023

Volltextzugriff (PDF)

187P Neoadjuvant cadonilimab (PD-1/CTLA-4 bispecific antibody) plus transhepatic arterial infusion chemotherapy (HAIC) for resectable multinodular CNLC Ib/IIa hepatocellular carcinoma (Car-Hero)

Annals of oncology, 2023-11, Vol.34, p.S1547-S1548

2023

Volltextzugriff (PDF)

1882O RENOTORCH: Toripalimab combined with axitinib versus sunitinib in first-line treatment of advanced renal-cell carcinoma (RCC) - A randomized, open-label, phase III study

Annals of oncology, 2023-10, Vol.34, p.S1011-S1012

2023

Volltextzugriff (PDF)

[19] Antibodies that recognize nitrotyrosine

Methods in Enzymology, 1996, Vol.269, p.201-209

1996

Volltextzugriff (PDF)

1D sodium ditetrazole coordination polymer obtained through in situ hydrothermal ligand synthesis

Inorganic chemistry communications, 2005, Vol.8 (1), p.58-60

2005

Volltextzugriff (PDF)

1 – 25 von 6.583

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(5.356)
Mit Volltextzugriff
(5.979)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

7 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(4.175)
Life Sciences & Biomedicine
(1.675)
Physical Sciences
(1.623)
Technology
(1.446)
Physics
(1.344)
Humans
(1.050)
Materials Science
(638)
Male
(603)
Female
(579)
Animals
(557)
Materials Science, Multidisciplinary
(543)
Exact Sciences And Technology
(524)
Biological And Medical Sciences
(464)
Chemistry
(396)
Adult
(367)
Engineering
(367)
Middle Aged
(359)
Computer Science
(349)
Physics, Particles & Fields
(323)
Medical Sciences
(298)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

1-Amino-1,2,3,4-tetrahydronaphthalene-2-carboxylic acid as a Tic mimetic: Application in the synthesis of potent human melanocortin-4 receptor selective agonists

100 Gbit/s WDM transmission at 2 µm: transmission studies in both low-loss hollow core photonic bandgap fiber and solid core fiber

1010P - Frequency of mutations in 21 hereditary breast and ovarian cancer susceptibility genes among 882 high-risk individuals

1010PFrequency of mutations in 21 hereditary breast and ovarian cancer susceptibility genes among 882 high-risk individuals

1036 A 24-WEEK, PARALLEL-GROUP, OPEN-LABEL, RANDOMIZED CLINICAL TRIAL COMPARING THE EARLY ANTIVIRAL EFFICACY OF TELBIVUDINE AND ENTECAVIR IN THE TREATMENT OF HBEAG-POSITIVE CHRONIC HEPATITIS B

1073 GENOME-SCALE CRISPR/CAS9 SCREENING REVEALS THE ROLE OF PSMD4 IN COLIBACTIN-MEDIATED CELL CYCLE ARREST

108 Denosumab in men with non-metastatic castration-resistant prostate cancer (CRPC) and PSA doubling time (PSADT) ≤6 months

108P Optimization of automatic emphysema detection in lung cancer screening dataset

A 112.5Gb/s ADC-DSP-Based PAM-4 Long-Reach Transceiver with >50dB Channel Loss in 5nm FinFET

118P Non-invasive plasma cell-free 5-hydroxymethylcytosine as promising biomarkers for early diagnosing gastrointestinal cancers

1213P HRD complete: A novel NGS assay for detecting homologous recombination repair (HRR) gene alterations in prostate cancer

1215 Ritlecitinib, an oral dual JAK3/TEC family kinase inhibitor, induces differential changes in immunological protein levels across Fitzpatrick skin types (FST) in patients with active nonsegmental vitiligo (NSV)

132TiP Dose escalation of chemoradiotherapy in locally advanced esophageal squamous cell carcinoma based on positron emission tomography response: A phase III, open-label, randomized, controlled trial (ESO-Shanghai 12)

(134) Symptom burden clusters in underserved Chinese American cancer patients

135P Simultaneous noninvasive imaging of LAG-3 and PD-L1 for noninvasive immunotyping in lung cancers

1378P A single-center, prospective, open-label, single-arm trial of sintilimab with paclitaxel and carboplatin as a neoadjuvant therapy for esophageal squamous carcinoma

152P A phase I study of HBM4003, an anti-CTLA-4 heavy chain only monoclonal antibody, in combination with toripalimab in advanced melanoma

155P Surufatinib plus toripalimab for second-line treatment of advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma, esophageal squamous cell carcinoma (ESCC) and neuroendocrine carcinoma (NEC): A multicenter, single-arm phase II study

172P Trastuzumab deruxtecan (T-DXd) in Chinese patients (pts) with previously treated HER2-positive locally advanced/metastatic gastric cancer (GC) or gastroesophageal junction adenocarcinoma (GEJA): Primary efficacy and safety from the phase II single-arm DESTINY-Gastric06 (DG06) trial

174P A real-world study of PD-1 inhibitors combined with TKIs for HCC with major vascular invasion as the conversion therapy: A prospective, non-randomized, open-label cohort study

181P TQB2450 (PD-L1 blockade) in combination with anlotinib as a perioperative treatment for patients with hepatocellular carcinoma at high risk of recurrence: Primary results from a prospective, single-arm, phase Ib study

187P Neoadjuvant cadonilimab (PD-1/CTLA-4 bispecific antibody) plus transhepatic arterial infusion chemotherapy (HAIC) for resectable multinodular CNLC Ib/IIa hepatocellular carcinoma (Car-Hero)

1882O RENOTORCH: Toripalimab combined with axitinib versus sunitinib in first-line treatment of advanced renal-cell carcinoma (RCC) - A randomized, open-label, phase III study

[19] Antibodies that recognize nitrotyrosine

1D sodium ditetrazole coordination polymer obtained through in situ hydrothermal ligand synthesis

Suchergebnisse filtern